ABSTRACT
INTRODUCTION
Several methods have been employed as measures of family planning. These include contraception and abortion (1) . None of these is without side effects. Numerous factors influence the choice of family planning method. In the developing countries, important factors are cost and easy accessibility, which have led to the use of traditional methods of contraception (2) . Traditional medicine has been used for the control of fertility in Nigeria for many years. This has led to continued interest among researchers in evaluating natural products used for fertility control (3) (4) (5) (6) (7) (8) (9) (10) (11) ; a common substance used locally is trona.
Trona, a sesquicarbonate or hydrated carbonate of sodium, is popularly called 'Kanwa' in the northern part of Nigeria where it mostly occurs as a deposit of saline lakes (12) . There are various varieties of trona; however, these have similar properties. Isolated chemical constituents are high amounts of sodium and calcium ions and low iron, potassium, magnesium, zinc, manganese, carbonates, sulphate, bicarbonates and chloride ions (13) . Although, trona is locally used for fertility control in Nigeria orally, there has been no scientific documentation to support this. This study thus evaluates the hormonal effects of trona, and its potential to cause fetal loss.
SUBJECTS AND METHODS
Trona was obtained from a local market in Ogbomoso and authenticated by AF Ajayi of the Department of Physiology, Ladoke Akintola University of Technology (LAUTECH), Ogbomoso, Oyo state, Nigeria.
Healthy male and female rats (of Wistar strain) of proven fertility and of comparable weights were obtained from the Animal House of the Department of Physiology, LAUTECH, Nigeria. All animals were housed in clean, stainless steel cages placed in well-ventilated room conditions (temperature: 28°C-31°C, 12-hour light-dark cycle, humidity of 45%-50%). They were also allowed to feed on pellets (Bendel Feeds and Flour Mill, Ewu, Edo, Nigeria) and water ad libitum. The animals were acclimatized for two weeks. This study was carried out following approval from the Departmental Ethics Committee on the use and care of experimental animals, and animals were handled according to the guidelines of the National Institutes of Health on the Care and Use of Laboratory Animals (14) .
Preparation of trona solution
The sample was carefully grounded with mortar and pestle, and sieved. Sample specimens were taken to the laboratory of Food Science and Engineering, LAUTECH, for extraction using lime and stored in a bottle under room temperature until used. Two hundred grams of trona was dissolved in one litre of lime to give a concentration of 200 mg/mL. The solution was reconstituted to give the required doses of 250 and 500 mg/kg body weight that was used in the study. The method of preparation and doses used in the study are as commonly used locally.
Determination of fetal loss
This was done as previously described (3, 15) . A fter the acclimatization period, vaginal smears were examined to study their oestrous cycle and ascertain the readiness for mating. Female rats were paired overnight with the male counterparts (ratio 1:1) in the stainless steel cages that provided free access to food and water. Again, the vaginal smear was examined every morning for presence of spermatozoa using a binocular microscope. The day on which spermatozoa was detected on vaginal smear was considered day 0 of pregnancy. Pregnant rats were randomized into three group (A, B and C) consisting of six rats each. During the 15 th -20 th day (organogenetic period) of pregnancy, group A, which is the control group, was given a single dose of 1.25 mL/kg body weight of lime with the aid of a metal oropharyngeal cannula, while groups B and C were given 250 mg/kg and 500 mg/kg body weight of trona extract, respectively. Body weight and behavioural changes were monitored daily throughout the experimental period. Twenty-four hours after the last dose (on the 21 st day), all the rats from each group were laparotomized under ether anaesthesia, and the following parameters were recorded: number of live fetuses, number of fetal loss, % fetal loss [(number of fetal loss/number of rats used)×100]. Blood samples were also collected for hormonal assay.
Standard assay kits for hormonal assay were used. Assay kits for hormonal assay (Randox Laboratory, Inc., Co Antrim, United Kingdom for cholesterol assay and Diagnostic Automation, Inc., Calabasas, CA, USA, for progesterone and oestradiol assay) were used. Serum progesterone oestradiol and cholesterol were quantitatively determined by enzymelinked immunosorbent assay (ELISA) following the procedure outlined in the manufacturer's protocol version which adopted the principle of Tietz (16) . The intra-and inter-assay variability was 8.1%.
The body weights of the experimental animals were determined and recorded on the first day (initial weight) and on the last day of the experiment prior to laparotomy (final weight). The body weight gain of each rat was evaluated as the difference between the initial and final weight.
Statistical analysis
The mean of six replicates ± standard error of mean (SEM) was calculated for all values (17) . Comparisons between the control and experimental groups were done using the Student t-test. Differences were considered statistically significant at p < 0.05.
RESULTS
There was no significant difference in the body weight gained across all the groups (Table 1) . Clinical toxicity symptoms such as respiratory distress, salivation, weight loss, dull eyes, diarrhoea and change in the appearance of fur were not observed in the animals. There was also no case of mortality in the experimental rats used. This suggests that trona was not clinically toxic to the experimental animals.
Treatment with 250 mg/kg body weight of the trona decreased the number of live fetuses by 60%, while no live fetus was observed in the 500 mg/kg body weight treated animals. Administration of 250 and 500 mg/kg body weight of trona resulted in 83.33% and 100% fetal loss, respectively, as indicated by the number of animals with dead fetuses during the laparotomy ( Table 2) . loss. A higher number of fetal loss in the 500 mg/kg body weight-treated is a pointer to the dose-dependent effect of trona in causing fetal loss. This finding is in consonance with previous studies that documented the potential phytochemicals in causing fetal loss (3, 5, 15) . Observations from this study also corroborate previous documentation of Alawa et al (13) that reported the contractile effects of trona.
The reduced levels of cholesterol and progesterone, and concomitant rise in oestradiol seen in the study could explain the activity of trona to cause fetal loss. Progesterone, a hormone of pregnancy, promotes endometrial function, nourishes the fertilized ovum, and keeps the uterus relaxed to carry pregnancy to term. The fall in serum progesterone level following trona administration may explain, at least in part, the fetal loss observed in the study (19) . The rise in oestradiol level in the study agrees with a previous study (20) that associated antifertility extracts with their oestrogenic activity. The elevated oestradiol level possibly resulted in an increase in protein synthesis, uterine weight, water uptake and retention of fluid, leading to ballooning of the uterus (21) . It may also have caused uterotrophic changes and vaginal opening (22) , rise in the uterine content of glucose, cholesterol, glycogen, alkaline phosphatase activity, and increased uterine contractility, thereby producing alterations in the uterine milieu and creating hostile conditions in the uterus (22) .
The effect of trona on pregnancy may also be attributed to its chemical constituents, especially the high levels of sodium and calcium ions, which are essential for uterine contraction. A rise in cystolic calcium initiates excitation-contraction coupling in uterine smooth muscle, while sodium increases the force of contraction (23, 24) . Findings in this study also showed that there was no significant difference in the body weight gained across all the groups. This might suggest that trona is non-toxic.
In conclusion, this study has demonstrated that trona causes fetal loss which may be attributed to the chemical constituents, especially sodium and calcium. This effect is possibly via an oestrogen-dependent mechanism. Data represent mean ± SEM (n = 6, *p < 0.05) Data represent mean ± SEM (n = 6)
Ajayi and Akhigbe Administration of trona significantly decreased the concentrations of serum progesterone and cholesterol, and increased serum oestradiol (Figure) .
DISCUSSION
The findings of this study revealed an interesting measure of fertility control. Pregnancy can be disrupted by interfering with the process of implantation or the mitotic division of the fetus with resultant embryonic loss (2, 18) .
The decrease in the number of live fetuses as well as increased number of dead fetuses seen in the present study is an indication that trona has the biological activity to cause fetal 
